FULC Stock Analysis: Buy, Sell, or Hold?

FULC - Fulcrum Therapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$3.84
0.20 (5.49%) ▲
5d: +6.37%
30d: +22.29%
90d: -48.66%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026

Get Alerted When FULC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: FULC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: FULC is currently trading at $3.84, which is considered fair relative to its 30-day fair value range of $2.92 to $5.41.

Technical Outlook: Technically, FULC is in a strong downtrend. Immediate support is located at $3.46, while resistance sits at $4.01. The stock is showing strong short-term momentum, up 5.5% recently.

Market Sentiment: FULC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.43 (+41.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $2.92 - $5.41
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 92.1%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.5%)
  • BULLISH: Trading 41.4% below Wall St target ($5.43)

Trading Range Analysis

30-Day Trading Range $2.92 - $5.41
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $3.46
Resistance Level $4.02
Current Trend Strong Downtrend
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -6.13
Wall Street Target $5.43 (+41.4%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 10:40 PM ET
Data refreshes hourly during market hours. Next update: 11:40 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for FULC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$57 51 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$276 55 HOLD
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$291 63 BUY
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD
IMVT
Immunovant Inc
STRONG BUY
14 analysts
$46 61 BUY

Advanced FULC Option Strategies

Professional options setups generated by AI based on today's FULC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for FULC

FULC Technical Chart FULC Price Prediction FULC Earnings Date FULC Investment Advisor FULC Fair Price Analyzer FULC Options Advisor FULC Options Chain FULC Options Analysis FULC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals